Key result
Non-viable myocardium on cardiac MRI is linked to akinesia on echocardiography in ~76% of segments.
Why the study?
Following myocardial infarction, patients may develop ventricular dysfunction or residual coronary disease requiring myocardial viability assessment, prompting comparison of cardiac MRI viability with echocardiographic wall motion abnormalities.
Does echocardiography wall motion abnormality correlate with cardiac MRI late gadolinium enhancement for assessing myocardial viability in patients with myocardial infarction?
Cross-Sectional (n=90)
Yes
Does echocardiography wall motion abnormality correlate with cardiac MRI late gadolinium enhancement for assessing myocardial viability in patients with myocardial infarction?
p-value: p=<0.001
Echocardiography-assessed wall motion abnormalities correlate significantly with cardiac MRI late gadolinium enhancement, suggesting it can be a reliable tool for predicting myocardial viability in resource-limited settings.
MRI LGE may better identify nonviable segments than echo wall motion; leaves open whether it changes revascularization decisions in post-MI patients.
Background and aim Coronary artery disease (CAD) is one of the major causes of morbidity and mortality worldwide. Following myocardial infarction (MI), patients may develop significant ventricular dysfunction, and many others may harbor a burden of residual coronary disease, for which viability assessment of the suspected myocardial territory may be needed. Thus, this study aimed to assess the viability of myocardium by cardiac magnetic resonance imaging (MRI) in patients with MI and compare it with wall motion abnormality in echocardiography. Methods An observational cross-sectional study was conducted at Shahid Gangalal National Heart Centre and Bir Hospital, Kathmandu, Nepal. A total of 90 patients with a history of MI who underwent cardiac MRI were enrolled from May 12, 2023, to May 11, 2024. Echocardiography was analyzed for wall motion abnormalities and left ventricular ejection fraction (LVEF), while cardiac MRI was analyzed for wall motion abnormalities, LVEF, and late gadolinium enhancement (LGE). Myocardial segments were divided into those with LGE ≤50% (viable) and those with LGE >50% (non-viable). Wall motion abnormality by echocardiography and LGE by cardiac MRI were assessed for each segment and compared. Results Out of a total of 1,530 myocardial segments in 90 patients, 431 segments showed LGE on cardiac MRI, out of which 38 segments had LGE ≤50%, and 393 segments had LGE >50%. Most of the myocardial segments with LGE on cardiac MRI were in the left anterior descending (LAD) artery territory. All 38 segments that showed LGE ≤50% showed hypokinesia on echocardiogram. None of these segments showed akinesia or dyskinesia on echocardiogram. The majority of the segments with LGE >50% showed akinesia on echocardiogram, followed by hypokinesia and dyskinesia. None of the segments with LGE >50% had normal wall motion. Conclusion Cardiac MRI is an accurate and reliable tool to assess cardiac volumes, function, and LGE, thus determining the extent and severity of infarcted myocardium. Wall motion abnormalities by echocardiography, based on their severity, can also help to predict which involved myocardium may be viable and thus benefit in resource-limited settings.
No takes yet. Share an insight, caveat, or question.
Bhatta et al. (2025) conducted a cross-sectional in Myocardial Infarction (n=90). Echocardiography vs. Cardiac Magnetic Resonance Imaging (MRI) was evaluated on Association between wall motion abnormality on echocardiography and late gadolinium enhancement (LGE) on cardiac MRI (p=<0.001). All myocardial segments identified as viable by cardiac MRI (LGE ≤50%) exhibited hypokinesia on echocardiography, whereas 76.1% of non-viable segments (LGE >50%) showed akinesia (p<0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: